Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sweco awarded additional contracts for Stockholm’s new metro

Sweco has won additional contracts in connection with the expansion of Stockholm’s metro between Fridhemsplan and Älvsjö. The project supports sustainable travel in a growing Stockholm with two important transport hubs where thousands of future passengers will change metro trains daily.“The continued confidence in Sweco to develop one of Stockholm’s most important infrastructure projects in modern times is highly gratifying. The project is creating efficient travel as well as good, safe environments. We have both the capacity and the ability to harness smart digital tools and innovative

Read original

Hunter Group ASA - Key information relating to the cash dividend

Oslo, 22 August 2022 Key information relating to the cash dividendto be paid by Hunter Group ASA: Dividend amount: NOK 1.50 per share Declared currency: NOK Last day including right: 23 August 2022 Ex-date: 24 August 2022 Record date: 25 August 2022 Payment date: 1 September 2022 Date of approval: 27 April 2022 (AGM) Contact: Erik A.S. Frydendal, CEO, ef@huntergroup.no, Ph.: +47 957 72 947 Lars M. Brynildsrud, CFO, lb@huntergroup.no, Ph.: +47 932 60 882 This information is published in accordance with the requirements of the Continuing Obligations.

Hunter Group ASA - Dividend Payment

Oslo, 22 August 2022 The board of directors of Hunter Group ASA (the “Company”) has decided to distribute a dividend of NOK 1.50 per share (excluding treasury shares). The decision is based on authority granted by the general meeting held on 27 April 2022. The distribution will be conducted as a reduction of the Company’s equity capital. It is the board’s intention to distribute the remaining excess capital from the vessel sales as soon as possible after the final ship has been delivered to her new owners. An announcement of key information will be published separately. Contact:

Hufvudstaden welcomes Aim’n to BIbliotekstan

Swedish training brand Aim’n is to open a pop-up store of approximately 120 square metres on Norrmalmstorg 1 in Bibliotekstan on 25 August. It will be the brand’s first independent store in Stockholm. Aim’n creates training and leisure clothing for women.Aim’n was founded in 2013 by Tekla Acs and Helen Van and has rapidly become a leading athleisure brand. Their ambition is to empower women through innovative and multifunctional design and enable them to reach their full potential.   -          “We’re delighted to welcome Aim’n to Bibliotekstan. The brand is an ideal complement to our

Kongsberg Automotive appoints new Head of Investor Relations

Zurich, August 22, 2022: Kongsberg Automotive (KA) has appointed Mads Langaard as the new Head of Investor Relations (IR), effective August 22, 2022. As the Head of Investor Relations, Mads will help communicate KA’s equity story and play a key role in strengthening the company’s relationships with shareholders, analysts, bondholders, and banks. Mads comes to KA from Frigaard Gruppen, where he has served as the Chief Financial Officer. He has a background in financial journalism and has worked with Finansavisen in Norway. Mads holds an Executive MBA from the Norwegian School of

Vinted UAB completes its offer to the shareholders of Rebelle AB (publ) , becoming the owner of approximately 96.7 per cent of the shares and extends the acceptance period

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or the United States or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important

Correction: INTERIM REPORT APRIL-JUNE 2022

Correction refers to the interim report being attached to the press release, which was missing in the press release earlier.SUMMARY OF THE INTERIM REPORT   During the second quarter, sales in regular wound healing products amounted toM SEK 0.5 (1.9). The Group's net turnover during the quarter amounted to MSEK 0.9 (2.2). Turnover during the second quarter of 2021 was affected by a larger one-off sale of approximately MSEK 0.9. The turnover of wound healing products in the first half of 2022 amounted to MSEK 2.3 (2.6), which indicates that sales within the Company's turnover during the

Andrés Rubio appointed as acting President and CEO of Intrum

The Board of Directors of Intrum AB (publ) (“Intrum”) has come to an agreement with Anders Engdahl, who will step down from his position as President and CEO of Intrum and leave the company with immediate effect. The Board has appointed current Board member Andrés Rubio as acting President and CEO. The recruitment of a permanent solution will commence during the autumn.“Anders Engdahl was internally recruited from the CFO role to the CEO position, with the specific intent of driving the ONE Intrum transformation, which is now underway after heavy lifting. Over the last couple of years, he

Enrique Banuelos appointed new Executive Chairman of Inzile

Present Board member Enrique Banuelos has been appointed Executive Chairman of the Bord of Directors of Inzile AB (publ). Former Chairman Håkan Örtenholm has left the board on his own request. We would like to thank Håkan Örtenholm for his dedication and leadership of the Board of Directors during his tenure.  For further information, please contact: Måns Sjöstedt, CEO Inzile, mans.sjostedt@inzile.com, +46 70 946 69 05 Peter Wergens, CFO Inzile, peter.wergens@inzile.com, +46 73 325 75 04

AutoStore: Mandatory notification of trade by primary insider

Primary insider in AutoStore Holdings Ltd. (AutoStore, OSE: AUTO), Viveka Ekberg, board member, has on 19 August 2022, acquired a total of 40,000 shares in AutoStore.Please see the attached form of notification and public disclosure for further information. This information is subject to the disclosure requirements in article 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act. For further information, please contact: Hiva Ghiri, VP Investor Relations, +47 958 66 790 hiva.ghiri@autostoresystem.com  About

INTERIM REPORT APRIL-JUNE 2022

SUMMARY OF THE INTERIM REPORT   During the second quarter, sales in regular wound healing products amounted toM SEK 0.5 (1.9). The Group's net turnover during the quarter amounted to MSEK 0.9 (2.2). Turnover during the second quarter of 2021 was affected by a larger one-off sale of approximately MSEK 0.9. The turnover of wound healing products in the first half of 2022 amounted to MSEK 2.3 (2.6), which indicates that sales within the Company's turnover during the second quarter of 2022 were affected due to the war in Ukraine, which caused disruptions in logistics chains and reduced

VIA Vika– A dazzling façade in the middle of Oslo

VIA Vika is part of a modern hub in the business district in Oslo. The building's impression changes depending on the point of view and the shape adapts to the city's streets. VIA Vika blends beautifully into the surroundings - if you step right outside the door, you will find the fjord, the culture and a vibrant city life. The architecture with its dazzling façade contributes to a vibrant city with facilities such as restaurants interspersed with office space in the same building. Not too long ago, there was another building standing on the same spot were VIA Vika is today. A

Report on Manager's Transactions in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 160 - 19 AUGUST 2022   Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives.     Name:   Jan RindboReason:   Reporting duty, CEOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   SharesTransaction:   SaleTrading date:   18

Crown Energy: Q2 report January-June 2022

SECOND QUARTER REPORT – APRIL-JUNE 2022 · Revenue amounted to SEK 10,334 thousand (5,683). · Operating loss amounted to SEK -7,467 thousand (-8,461). · Net financial items amounted to SEK 2,328 thousand (5,925). · Unrealised changes in property values amounted to SEK 2,931 thousand (-5,891). · Result before tax amounted to SEK -2,207 thousand (-8,426) and result after tax amounted to SEK -17,509 thousand (-8,669), corresponding to SEK -0.04(-0.02) per share.      HALF YEAR REPORT – JANUARY-JUNE 2022 ·  Revenue amounted to SEK 17,647 thousand (10,562). ·

Nordea Bank Abp: Repurchase of own shares on 19.08.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares19.08.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 19.08.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 255,924 9.66 2,471,509.25CEUX 248,595 9.65 2,398,524.82TQEX 0 - 0.00XSTO 282,514 9.64 2,723,280.92XCSE

DanCann Pharma A/S postpones quarterly report for Q2 2022

COPENHAGEN, Denmark, 19 August 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the board of directors of DanCann Pharma has decided to postpone the report for the second quarter until Wednesday, August 31, 2022. The previous date was set for August 25, 2022.About DanCann Pharma DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution Company based in Denmark.

Borr Drilling Limited - Exercise of Option to Purchase Additional Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Hamilton, Bermuda, August 19, 2022. Borr Drilling Limited (the “Company”) (NYSE and OSE: BORR) announces today that the underwriters of the Company’s previously announced US offering of its US common shares (the “Offering”) have exercised their option to purchase an additional 6,918,627 common shares at the public offering

Elkem ASA - Buyback of shares

Oslo, 19 August 2022 Please see below information about transactions made under the share buyback programme for Elkem ASA. · Date on which the buyback programme was announced: 21 July 2022 · The duration of the buyback programme: 21 July 2022 to 23 September 2022 · Size of the buyback programme: Up to 5,000,000 shares From 13 August 2022 until 19 August 2022, Elkem ASA has purchased a total of 625,000 own shares at the Oslo Stock Exchange at an average price of NOK 37.4080 per share. Aggregated overview of transactions per day: Date Aggregated Weighted

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 19.08.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    19.08.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 19.08.2022   Date 19.08.2022  Exchange transaction Buy  Share class ALEX  Amount 250  Average price/share 8.2000   EURHighest price/share 8.2000   EURLowest price/share 8.2000   EURTotal price 2,050.00 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 19.08.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.08.2022

Fiskars Corporation   Stock Exchange Release 19.08.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 19.08.2022   Date 19.08.2022  Exchange transaction Buy  Share class FSKRS  Amount  6,500  Average price/share 18.5001 EURHighest price/share 18.5800 EURLowest price/share 18.3000 EURTotal price 120,250.65 EUR        The shares held by Fiskars Corporation on 19.08.2022:   FSKRS 969,405       On

Metso Outotec Corporation: SHARE REPURCHASE 19.8.2022

Metso Outotec Corporation  ANNOUNCEMENT  19.8.2022 Metso Outotec Corporation: SHARE REPURCHASE 19.8.2022 In the Helsinki Stock Exchange Trade date           19.8.2022Bourse trade         BuyShare                  MOCORPAmount             350 000 SharesAverage price/ share    8,2437 EURTotal cost            2 885 295,00 EUR Metso Outotec Corporation now holds a total of 3 038 505 sharesincluding the shares repurchased on 19.8.2022 On behalf of Metso Outotec Corporation

Notification of trades

Reference is made to Aker BP's press release from 8 August 2022, where the company announced its plan to buy up to 1,000,000 own shares in connection with the company's employee share saving plan. In the period from 15 August to 19 August, the company purchased 250,000 shares at an average price of NOK 324.35. An overview of the transactions, and a detailed specification of each individual trade, are attached to this announcement and available at www.newsweb.no. After these transactions, Aker BP ASA owns a total of 775,655 own shares, corresponding to 0.12 percent of the company's

CS MEDICA A/S: Based on a dialog with a European based veterinarian company, their vet product line is pulled forward- engaging a targeted marked of US$1 billion/yearly

CS MEDICA A/S (“CS MEDICA” or “the Company”) announces today that the Company have entered in dialog with a European based veterinarian company, with a long track record, branding their products to veterinary practices throughout Europe. The Company is hereby looking into entering the veterinarian market with the Company’s Veterinary Medical CBD Products before schedule.CS MEDICA have brought effective medical CBD products to humans, and now they want to utilize their knowledge of effective Medical CBD Products by bringing the veterinarian (vet) Medical CBD Products to the family’s best

There are no items matching the current filter
There are no more items matching the current filter
Back to top